KAMADA Trademark

Trademark Overview


On Monday, April 18, 2016, a trademark application was filed for KAMADA with the United States Patent and Trademark Office. The USPTO has given the KAMADA trademark a serial number of 79194198. The federal status of this trademark filing is Section 71 & 15 - ACCEPTED AND ACKNOWLEDGED as of Friday, August 2, 2024. This trademark is owned by KAMADA LTD.. The KAMADA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals, namely, plasma derived and recombinant immunoglobulins; pharmaceuticals, namely, plasma derived and recombinant proteins for treating pulmonary diseases, congenital Alpha-1 Antitrypsin deficiency, post-exposure prophylaxis against viral infection, preventing and treating immune tolerance based diseases, treating immunological disorders, and treating inflammatory diseases; pharmaceuticals, namely, coagulation factors for bleeding disorders; plasma-derived protein preparations for therapeutic use; vaccines; pharmaceutical preparations for the treatment of lung diseases; pharmaceutical preparations for the treatment or prevention of thrombo-embolic disorders; pharmaceutical preparations for anesthesia or analgesia for surgery
kamada

General Information


Serial Number79194198
Word MarkKAMADA
Filing DateMonday, April 18, 2016
Status739 - Section 71 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateFriday, August 2, 2024
Registration Number5372047
Registration DateTuesday, January 9, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 25, 2017

Trademark Statements


Goods and ServicesPharmaceuticals, namely, plasma derived and recombinant immunoglobulins; pharmaceuticals, namely, plasma derived and recombinant proteins for treating pulmonary diseases, congenital Alpha-1 Antitrypsin deficiency, post-exposure prophylaxis against viral infection, preventing and treating immune tolerance based diseases, treating immunological disorders, and treating inflammatory diseases; pharmaceuticals, namely, coagulation factors for bleeding disorders; plasma-derived protein preparations for therapeutic use; vaccines; pharmaceutical preparations for the treatment of lung diseases; pharmaceutical preparations for the treatment or prevention of thrombo-embolic disorders; pharmaceutical preparations for anesthesia or analgesia for surgery

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, October 24, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameKAMADA LTD.
Party Type30 - Original Registrant
Legal Entity Type11 - Company
AddressNess Ziona 74036
IL

Party NameKAMADA LTD.
Party Type20 - Owner at Publication
Legal Entity Type11 - Company
AddressIL

Party NameKAMADA LTD.
Party Type10 - Original Applicant
Legal Entity Type11 - Company
AddressIL

Trademark Events


Event DateEvent Description
Tuesday, October 25, 2016NON-FINAL ACTION WRITTEN
Thursday, October 20, 2016SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, October 24, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, October 24, 2016ASSIGNED TO EXAMINER
Wednesday, October 26, 2016NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, October 27, 2016REFUSAL PROCESSED BY MPU
Thursday, October 27, 2016NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, December 7, 2016NON-FINAL ACTION WRITTEN
Friday, October 28, 2016APPLICATION FILING RECEIPT MAILED
Friday, November 11, 2016REFUSAL PROCESSED BY IB
Wednesday, December 7, 2016LETTER OF PROTEST EVIDENCE FORWARDED
Wednesday, December 7, 2016NON-FINAL ACTION MAILED
Thursday, January 26, 2017REFUSAL PROCESSED BY IB
Monday, June 5, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 5, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 8, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 14, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 5, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 25, 2017PUBLISHED FOR OPPOSITION
Tuesday, July 25, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, August 24, 2017EXTENSION OF TIME TO OPPOSE RECEIVED
Sunday, December 3, 2017EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Tuesday, January 9, 2018REGISTERED-PRINCIPAL REGISTER
Monday, April 9, 2018FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Monday, April 16, 2018FINAL DISPOSITION PROCESSED
Monday, April 16, 2018FINAL DISPOSITION NOTICE SENT TO IB
Friday, May 25, 2018FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, January 9, 2023COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Tuesday, September 19, 2023TEAS SECTION 71 & 15 RECEIVED
Saturday, February 3, 2024NEW REPRESENTATIVE AT IB RECEIVED
Monday, May 13, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, August 2, 2024REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Friday, August 2, 2024NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED